• Home
  • Mutual Funds
  • Aditya Birla Sun Life Pharma & Healthcare Fund Growth

Aditya Birla Sun Life Pharma & Healthcare Fund Growth Return

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
This Fund:
Sensex:
BankFD:

Showing Funds Performance since Sep 07, 2020

Aditya Birla Sun Life Pharma & Healthcare Fund Growth Fund Overview

Min. investment

SIP ₹100 & Lump. ₹1000

AUM (Fund size)

₹1,011 Cr

Lock In Period

N/A

Expense Ratio

2.28

Exit Load

For redemption/switchout of units on or before 30 days from the date of allotment: 1.00% of applicable NAV. For redemption/switch-out of units after 30 days from the date of allotment: Nil.

Benchmark

BSE Healthcare Total Return

Aditya Birla Sun Life Pharma & Healthcare Fund Growth Calculate Returns

You would have got

close_grey_icon
No Data Found
Your Investment Amount
  • 1
  • 2
  • 3
  • 4
  • 5

Growth Review

DurationFund Return(%)Category Average(%)Category Best(%)
1M2.910.673.69
6M20.292.9025.25
1Y17.195.7420.19
3Y20.8815.5993.81

Portfolio Analysis

  • Equity: 97.86%
  • Debt: 2.15%
  • Others
As on: 2026-06-30
View allocation % by

1. Sun Pharmaceutical Industries Limited12.09%
2. J.B. Chemicals & Pharmaceuticals Limited4.71%
3. Torrent Pharmaceuticals Limited4.68%
4. Aurobindo Pharma Limited4.55%
5. Ajanta Pharmaceuticals Limited4.38%
6. Mankind Pharma Ltd3.92%
7. Lupin Limited3.74%
8. SAI Life Sciences Ltd3.50%
9. Abbott India Limited3.26%
10. Emcure Pharmaceuticals Ltd3.23%
11. Cipla Limited2.93%
12. IPCA Laboratories Limited2.55%
13. Gland Pharma Limited2.48%
14. Shilpa Medicare Ltd2.41%
15. CORONA Remedies Ltd2.28%
16. Procter & Gamble Health Limited2.20%
17. Alkem Laboratories Limited1.93%
18. Divi's Laboratories Limited1.69%
19. Dr. Reddys Laboratories Limited1.33%
20. Pfizer Limited1.23%
21. Biocon Limited1.12%
22. ANTHEM BIOSCIENCES LIMITED1.08%
23. Piramal Pharma Ltd1.06%
24. Syngene International Limited0.82%
25. GlaxoSmithKline Pharmaceuticals Limited0.79%
26. Jubilant Pharmova Ltd0.61%

1. Apollo Hospitals Enterprise Limited7.30%
2. Fortis Healthcare Limited3.21%
3. Thyrocare Technologies Limited1.93%
4. Jupiter Life Line Hospitals Ltd1.85%
5. Dr. Lal Path Labs Limited1.59%
6. METROPOLIS HEALTHCARE LIMITED1.44%
7. Vijaya Diagnostic Centre Limited1.05%
8. Suraksha Diagnostic Ltd0.90%
9. Max Healthcare Institute Limited0.78%

1. SANOFI CONSUMER HEALTHCARE1.44%

About Fund Aditya Birla Sun Life Pharma & Healthcare Fund Growth

Aditya Birla Sun Life Pharma & Healthcare Fund Growth managed by Aditya Birla Sun Life Mutual Fund,is a Healthcare & Pharmascheme with Assets Under Management of ₹1,011 Crore. The fund benchmarks its performance against the BSE Healthcare Total Return while maintaining an expense ratio of 2.28. Under the expert guidance of Dhaval Shah ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.

Fund Managers

Dhaval Shah

Mr. Dhaval Shah holds B.Com, CFA, MMS - Finance (Post graduation). He has worked with Morgan Stanley Investment Management, Reliance Capital Asset Management Ltd. and Edelweiss Securities.

Peer Comparison

Fund NameRatingsAUMExpense Ratio
DSP Healthcare Fund Growth33,514 CR1.97
LIC MF Healthcare Fund Growth192 CR2.84
Aditya Birla Sun Life Pharma & Healthcare Fund Growth21,010 CR2.28
SBI Healthcare Opportunities Fund Growth34,997 CR2.01
UTI Healthcare Fund Growth31,307 CR2.26
Fund Name1Y3Y
This FundDSP Healthcare Fund Growth9.353170.287
This FundLIC MF Healthcare Fund Growth10.1974.4043
This FundAditya Birla Sun Life Pharma & Healthcare Fund Growth14.532976.6618
This FundSBI Healthcare Opportunities Fund Growth16.2886.678
This FundUTI Healthcare Fund Growth12.746987.0453

Aditya Birla Sun Life Pharma & Healthcare Fund Growth FAQs

Aditya Birla Sun Life Pharma & Healthcare Fund Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.

The expense ratio of Aditya Birla Sun Life Pharma & Healthcare Fund Growth is 2.28. This expense ratio is calculated by dividing the fund's operating expenses by its net assets.

Aditya Birla Sun Life Pharma & Healthcare Fund Growth’s fund performance is as follows:
  • 1 Month : 2.91%
  • 6 Months : 20.29%
  • 1 Year : 17.19%
  • 3 Years : 20.88%
Returns of Aditya Birla Sun Life Pharma & Healthcare Fund Growth are updated daily based on NAV of ₹ 36.4 as on Aug 03,2026. Since inception, the return has been 76.61%.

You can invest in Aditya Birla Sun Life Pharma & Healthcare Fund Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.

The fund size (AUM) of Aditya Birla Sun Life Pharma & Healthcare Fund Growth is ₹1,011 crore. It changes based on market performance, inflows, and outflows.

You can track your investment in Aditya Birla Sun Life Pharma & Healthcare Fund Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.